The Story Of Our Firm | En Español
 Home    Lawyers   Litigation   Why Choose Us?   Results   Search

Drugs heparin

March 7, 2008 Update

in this section: FDA Heparin FAQs | Baxter Heparin Label Errors | Heparin Deaths | Heparin Complications | March 7, 2008 Update | Heparin Packaging | FDA Import Alert | FDA: Analyzing the Contaminant | Adverse Reactions | Heparin Warning Letter


Bookmark This Page Print This Page Email This Page

FDA Recall:  Updated Questions and Answers on Heparin Sodium Injection (Baxter)

On March 7, 2008, the FDA released updated FAQs with regard to the recall of Heparin products manufactured by Baxter. If you or a loved one has been harmed, please complete the form below for a complimentary review of your potential lawsuit.

Q. What has FDA recently announced about heparin?
A. Adverse events, including deaths, have been associated with the use of heparin, a blood-thinning drug that contained active pharmaceutical ingredient (API) from China. In February 2008, Baxter Healthcare Corporation recalled multi-dose and single-dose vials of heparin sodium for injection as well as HEP-LOCK heparin flush products. After launching a disciplined, methodical examination, FDA scientists have identified a previously unknown contaminant in the heparin. The agency does not have proof that this contaminant is causing the adverse events. There is an association, but not a direct causal link at this time. The agency has made available information on two tests that FDA scientists have conducted to detect the heparin-like substance, and recommend their use to manufacturers and suppliers for screening the heparin API.

Q. What steps has FDA taken?
A. Along with overseeing the recall, FDA scientists have:

  • Provided recommendations to health care professionals about strategies to limit the occurrence or severity of adverse reactions in cases where the use of heparin is medically necessary and Baxter heparin is the only heparin product available.
  • Launched a far-ranging investigation in the United States and abroad.
  • Inspected a New Jersey facility to find out whether the heparin could have been contaminated by its packaging.
  • Traveled to China to perform a thorough check of the plant that manufactures the heparin ingredient.
  • Notified FDA's key regulatory international partners.
  • Worked closely with the manufacturer and experts in academia and private laboratories to carry out a thorough chemical analysis of the suspect products. The agency made available information on two tests that FDA scientists have conducted to detect the heparin-like substance, and recommended their use to manufacturers and suppliers for screening the heparin active pharmaceutical ingredient (API).
  • Worked to ensure that there exists a safe and adequate supply of heparin to the U.S. market.

Q. What kind of testing did FDA scientists conduct?
A. After conventional testing did not prove useful in detecting these contaminants, FDA experts developed new test methods that use existing state-of-the-art technologies such as nuclear magnetic resonance, capillary electrophoresis, enzymatic kinetics, and bioassay.

Q. What were the results of the testing?
A. FDA scientists determined that the sampled products contained 5 percent to 20 percent of a heparin-like compound—a contaminant that mimicked heparin activity so closely that it was not recognized by routine testing.

Q. How did the contaminant get into the product?
A. At this point, FDA does not know how the contaminant got into the heparin active pharmaceutical ingredient (API). The agency is continuing to aggressively investigate the situation. 

If you were harmed after being administered heparin, please complete the form below and a representative of our firm will contact you as soon as possible.

Click To Talk To Us Online

Please complete the following questionnaire:

Email Address
When were you given Heparin?
Why were you given Heparin?
How were you injured by Heparin?
What was the date of your Heparin injury?
Name
Phone Number (optional)


see also:

Adverse Reactions FDA Reports Adverse Reactions Related to Heparin--Free Lawsuit Info
FDA Monitors Contaminated Heparin and Adverse Reactions in Patients

Heparin Packaging American Health Packaging Recalls Heparin Products--Free Lawsuit Info
FDA announces additional Heparin recall from American Health Packaging

FDA Health Advisory FDA Issues Advisory on Heparin Due to Health Risks--Free Lawsuit Info
Did You Suffer Adverse Reaction After Heparin Injection? Lawsuit info


Name Phone Email
Do you have a legal question? Ask us!   strictly confidential
Your Question

Click here
for a free case review



$53 million verdict — brake mechanic suffering from mesothelioma

$13.5 million verdict — one of the very first Vioxx trial cases

$15 million settlement — man wound up a paraplegic due to negligent hospital care

$37 million verdict — 2 asbestos lung cancer plaintiffs

$47 million verdict — boilermaker who died from mesothelioma

$75 million verdict — historic consolidated trial involving men who had worked at the Brooklyn Navy Yard in the 1940s and 1950s

$12.7 million verdict — iron worker who was injured due to unsafe working conditions

$64.65 million award — 4 asbestos plaintiffs

$17.5 million — consolidated trial of 5 mesothelioma victims

$25 million jury verdict — brake reliner

$5.8 million settlement — failure to perform timely C-Section

$30 million verdict — 7 former power-plant workers suffering from asbestos-related illnesses

$6 million settlement — pediatric malpractice case

$14 million consolidated verdict — 5 asbestos-related cancer suits: shipyards/powerhouses/construction

$8 million settlement — obstetrical malpractice resulted in neurological deficits

$3.5 million — 2 asbestos exposure cases

$600,000 settlement — motor vehicle negligence resulting in serious injury

$44 million verdict — 5 asbestos cases, including $11.6 million awarded to widow of sheet metal worker who died of mesothelioma

$1.6 million settlement — suicide after premature hospital discharge

$2.6 million settlement — ill-fitting prosthesis caused decubitus ulcers

$1.5 million settlement — construction worker fell off elevated train tracks

$750,000 settlement — defective construction equipment resulted in serious injury to worker



Ask a Free Question:
Were you injured?

check for your response [login]
For legal help anywhere in the U.S.
A nationally-recognized personal injury law firm, Weitz & Luxenberg is committed to helping clients win cases, get the compensation to which they’re entitled and continue with their lives. In just over 20 years, we’ve collected more than $1.3 billion for plaintiffs.